Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis Burmester, G. R., Fiore, S., Hu, C., Fay, J., Lee, E., Genovese, M. C. WILEY. 2017

View details for Web of Science ID 000411824105324